Targegen, Inc. is a biotechnology company based in Bridgewater, NJ, specializing in the development of innovative therapeutics for the treatment of various diseases. The organization focuses on harnessing advanced molecular technologies to create targeted therapies, particularly in the fields of oncology and autoimmune disorders. With a commitment to scientific excellence, Targegen aims to address unmet medical needs through its research initiatives and collaborative efforts within the biopharmaceutical industry.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 10 2026

13 Patents

#20 in Bridgewater, NJ

#896 in New Jersey

#23,898 in US

#45,181 in the World

Bridgewater, NJ, United States of America

Targegen, Inc.

Forward Citations = 454

19 inventors:

Glenn Noronha (10 out of 16 patents)

John Hood (8 out of 123 patents)

Elena Dneprovskaia (8 out of 11 patents)

4. Chi Ching Mak (7 out of 34 patents)

5. Richard M Soll (7 out of 71 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Targegen, Inc.. Retrieved from https://idiyas.com/company/targegen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]